Sangamo Therapeutics
SGMO
#9354
Rank
A$0.13 B
Marketcap
A$0.38
Share price
5.35%
Change (1 day)
-58.74%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$32.87 Million. In 2024 the company made an earning of -A$0.15 Billion, an increase over its 2023 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion19.76%
2024 -A$0.15 Billion-17.27%
2023 -A$0.18 Billion-40.88%
2022 -A$0.3 Billion9.79%
2021 -A$0.27 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.16 Billion36.33%
2018 -A$0.12 Billion36.89%
2017 -A$81.35 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$67.63 Million75.62%
2014 -A$38.52 Million0.13%
2013 -A$38.46 Million
2011 -A$51.71 Million43.66%
2010 -A$35.99 Million28.52%
2009 -A$28.01 Million-23.55%
2008 -A$36.63 Million2.45%
2007 -A$35.76 Million19.5%
2006 -A$29.92 Million50.78%
2005 -A$19.85 Million75%
2004 -A$11.34 Million-33.25%
2003 -A$16.99 Million-62.27%
2002 -A$45.03 Million102.82%
2001 -A$22.2 Million23.21%
2000 -A$18.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.42 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.95 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.24 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.63 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.14 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.36 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.83 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.69 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA